GSK (NYSE:GSK) Downgraded to Buy Rating by StockNews.com
GSK (NYSE:GSK – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Wednesday. A number of other analysts also recently weighed in on GSK. BNP Paribas began coverage on shares of GSK in a report on Tuesday. They issued […]
GSK (NYSE:GSK – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Wednesday. A number of other analysts also recently weighed in on GSK. BNP Paribas began coverage on shares of GSK in a report on Tuesday. They issued […]
